Related Experiment Videos
Adjuvant therapy for osteosarcoma: preoperative and postoperative treatment
Cancer Treatment Reports
|February 1, 1978
Summary
This study on osteogenic sarcoma found that 85% of patients survived disease-free for a median of 11 months after treatment. Limb salvage was successful in most patients, with some experiencing recurrence.
Area of Science:
- Orthopedic Oncology
- Surgical Oncology
- Medical Oncology
Background:
- Osteogenic sarcoma presents a significant challenge in pediatric and young adult oncology.
- Effective treatment strategies are crucial to improve survival rates and minimize recurrence.
- Limb salvage surgery is a key goal in managing localized osteosarcoma.
Purpose of the Study:
- To evaluate the efficacy of postoperative adjuvant chemotherapy or chemoimmunotherapy in reducing distant metastases in osteogenic sarcoma.
- To determine if preoperative chemotherapy and radiation therapy can achieve in situ tumor cell destruction.
Main Methods:
- Prospective study involving 17 consecutive patients with osteogenic sarcoma.
- Assessment of postoperative adjuvant treatments (chemotherapy/chemoimmunotherapy).
- Evaluation of preoperative chemotherapy and radiation therapy protocols.
Main Results:
- 14 out of 17 patients (85%) remain alive and disease-free with a median survival of 11 months.
- Three patients experienced disease recurrence (one local, two pulmonary metastases).
- Successful limb salvage was achieved in 12 patients using cadaver allografts and in one patient with radiation therapy.
Conclusions:
- Postoperative adjuvant therapies show promise in managing osteogenic sarcoma, with a high rate of disease-free survival.
- Preoperative treatments may contribute to tumor control, facilitating limb salvage.
- Further research is warranted to optimize multimodal treatment strategies for osteogenic sarcoma.